Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following lassa virus exposure in cynomolgus macaques

mBio

Volumn 9, Issue 5, 2018, Pages 1-14

  Cashman, Kathleen A ^a   Wilkinson, Eric R ^a   Zeng, Xiankun ^a   Cardile, Anthony P ^a   Facemire, Paul R ^a   Bell, Todd M ^a   Bearss, Jeremy J ^a   Shaia, Carl I ^a   Schmaljohn, Connie S ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

ANCA; ANCA associated vasculitis; Anti neutrophilic cytoplasmic antibodies; Autoimmune associated vasculitis; Autoimmunity; Brainstem auditory evoked response; Cynomolgus macaque; Deafness; Immune mediated vasculitis; Lassa fever; Lassa virus; Microscopic polyangiitis; Nonhuman primate; Polyarteritis nodosa; Sensorineural hearing loss; Vasculitides; Viral hemorrhagic fever; Viral infection; Virus associated deafness

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASE; BRAIN; COMPLICATION; CYTOCHEMISTRY; DISEASE MODEL; INNER EAR; LASSA FEVER; MACACA FASCICULARIS; MICROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; SYSTEMIC VASCULITIS; VIROLOGY;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; DISEASE MODELS, ANIMAL; EAR, INNER; HEARING LOSS, SENSORINEURAL; HISTOCYTOCHEMISTRY; LASSA FEVER; MACACA FASCICULARIS; MICROSCOPY; SYSTEMIC VASCULITIS;

EID: 85055648125     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mbio.01896-18     Document Type: Article

References (55)

1. Liang Y, Lan S, Ly H. 2009. Molecular determinants of Pichinde virus infection of guinea pigs–a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci 1171:E65–E74. https://doi.org/10.1111/j.1749-6632.2009.05051.x.
2. Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, Momoh M, Grant DS, Garry RF. 2011. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J 8:478. https://doi.org/10.1186/1743-422X-8-478.
3. Cummins D. 1992. Rats, fever and sudden deafness in Sierra Leone. Trop Doct 22:83–84.
4. Liao BS, Byl FM, Adour KK. 1992. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg 106:226–229. https://doi.org/10.1177/019459989210600303.
5. Mateer EJ, Huang C, Shehu NY, Paessler S. 2018. Lassa fever-induced sensorineural hearing loss: a neglected public health and social burden. PLoS Negl Trop Dis 12:e0006187. https://doi.org/10.1371/journal.pntd.0006187.
6. Okokhere PO, Ibekwe TS, Akpede GO. 2009. Sensorineural hearing loss in Lassa fever: two case reports. J Med Case Rep 3:36. https://doi.org/10.1186/1752-1947-3-36.
7. Simmons FB. 1993. Lassa fever and sudden hearing loss. Otolaryngol Head Neck Surg 109:559.
8. Booth J. 1979. Diagnosis and management of sudden fluctuant senso-rineural hearing loss, p 737–783. In Ballantyne JG, Groves J (ed), Scott-Brown’s diseases of the ear, nose, and throat, vol 4. Butterworth’s, London, United Kingdom.
9. Rybak LP. 1990. Deafness associated with Lassa fever. JAMA 264:2119. https://doi.org/10.1001/jama.1990.03450160089037.
10. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, Fisher-Hoch SP. 1990. Acute sensorineural deafness in Lassa fever. JAMA 264:2093–2096. https://doi.org/10.1001/jama.1990.03450160063030.
11. Ibekwe TS, Okokhere PO, Asogun D, Blackie FF, Nwegbu MM, Wahab KW, Omilabu SA, Akpede GO. 2011. Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Otorhinolaryngol 268:197–201. https://doi.org/10.1007/s00405-010-1370-4.
12. Hensley LE, Smith MA, Geisbert JB, Fritz EA, Daddario-DiCaprio KM, Larsen T, Geisbert TW. 2011. Pathogenesis of Lassa fever in cynomolgus macaques. Virol J 8:205. https://doi.org/10.1186/1743-422X-8-205.
13. Yun NE, Ronca S, Tamura A, Koma T, Seregin AV, Dineley KT, Miller M, Cook R, Shimizu N, Walker AG, Smith JN, Fair JN, Wauquier N, Bockarie B, Khan SH, Makishima T, Paessler S. 2016. Animal model of sensorineural hearing loss associated with Lassa virus infection. J Virol 90:2920–2927. https://doi.org/10.1128/JVI.02948-15.
14. Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL. 1980. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis 141:580–589. https://doi.org/10.1093/infdis/141.5.580.
15. Lassiter FD. 1998. The string-of-beads sign. Radiology 206:437–438. https://doi.org/10.1148/radiology.206.2.9457197.
16. Stroup SP, Herrera SR, Crain DS. 2007. Bilateral testicular infarction and orchiectomy as a complication of polyarteritis nodosa. Rev Urol 9:235–238.
17. Teichman JM, Mattrey RF, Demby AM, Schmidt JD. 1993. Polyarteritis nodosa presenting as acute orchitis: a case report and review of the literature. J Urol 149:1139–1140. https://doi.org/10.1016/S0022-5347 (17)36322-X.
18. Flaherty J, Bradley EL, III. 1999. Acute pancreatitis as a complication of polyarteritis nodosa. Int J Pancreatol 25:53–57. https://doi.org/10.1385/IJGC:25:1:53.
19. Yokoi Y, Nakamura I, Kaneko T, Sawayanagi T, Watahiki Y, Kuroda M. 2015. Pancreatic mass as an initial manifestation of polyarteritis nodosa: a case report and review of the literature. World J Gastroenterol 21: 1014–1019. https://doi.org/10.3748/wjg.v21.i3.1014.
20. Churg J, Churg A. 1989. Idiopathic and secondary vasculitis: a review. Mod Pathol 2:144–160.
21. Lin J, Chen B, Wang JH, Zeng MS, Wang YX. 2006. Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels 21:395–398. https://doi.org/10.1007/s00380-006-0918-0.
22. Webb AA, Cullen CL, Lamont LA. 2006. Brainstem auditory evoked responses and ophthalmic findings in llamas and alpacas in Eastern Canada. Can Vet J 47:74–77.
23. Nakashima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H, Liu X, Nuttall AL. 2003. Disorders of cochlear blood flow. Brain Res Brain Res Rev 43:17–28. https://doi.org/10.1016/S0165-0173(03)00189-9.
24. Jenkins HA, Pollak AM, Fisch U. 1981. Polyarteritis nodosa as a cause of sudden deafness. A human temporal bone study. Am J Otolaryngol 2:99–107. https://doi.org/10.1016/S0196-0709(81)80026-9.
25. Gussen P. 1977. Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 217:263–271. https://doi.org/10.1007/BF00465544.
26. Joglekar S, Deroee AF, Morita N, Cureoglu S, Schachern PA, Paparella M. 2010. Polyarteritis nodosa: a human temporal bone study. Am J Otolaryngol 31:221–225. https://doi.org/10.1016/j.amjoto.2009.02.006.
27. Wolf M, Kronenberg J, Engelberg S, Leventon G. 1987. Rapidly progressive hearing loss as a symptom of polyarteritis nodosa. Am J Otolaryngol 8:105–108. https://doi.org/10.1016/S0196-0709(87)80032-7.
28. Amor Dorado JC, Barreira Fernández MDP, Regueiro Villarin S, González-Gay MA. 2009. Audiovestibular manifestations in systemic vasculitis. Acta Otorrinolaringol Esp 60:432–442. (In Spanish.) https://doi.org/10.1016/j.otorri.2009.01.012.
29. Berrettini S, Ferri C, Ravecca F, LaCivita L, Bruschini L, Riente L, Mosca M, Sellari-Franceschini S. 1998. Progressive sensorineural hearing impair-ment in systemic vasculitides. Semin Arthritis Rheum 27:301–318. https://doi.org/10.1016/S0049-0172(98)80051-6.
30. Lightfoot RW, Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL. 2010. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093. https://doi.org/10.1002/art.1780330805.
31. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11. https://doi.org/10.1002/art.37715.
32. Jennette JC. 2013. Overview of the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Clin Exp Nephrol 17:603–606. https://doi.org/10.1007/s10157-013-0869-6.
33. Grau GE, Roux-Lombard P, Gysler C, Lambert C, Lambert PH, Dayer JM, Guillevin L. 1989. Serum cytokine changes in systemic vasculitis. Immunology 68:196–198.
34. Guillevin L. 2004. Virus-induced systemic vasculitides: new therapeutic approaches. Clin Dev Immunol 11:227–231. https://doi.org/10.1080/17402520400001744.
35. Saadoun D, Bieche I, Authier FJ, Laurendeau I, Jambou F, Piette JC, Vidaud M, Maisonobe T, Cacoub P. 2007. Role of matrix metalloprotei-nases, proinflammatory cytokines, and oxidative stress-derived mole-cules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56:1315–1324. https://doi.org/10.1002/art.22456.
36. Saadoun D, Bieche I, Maisonobe T, Asselah T, Laurendeau I, Piette JC, Vidaud M, Cacoub P. 2005. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 52:2917–2925. https://doi.org/10.1002/art.21270.
37. Kikuchi K, Hoashi T, Kanazawa S, Tamaki K. 2005. Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa. J Am Acad Dermatol 53:57–61. https://doi.org/10.1016/j.jaad.2005.02.018.
38. de Menthon M, Lambert M, Guiard E, Tognarelli S, Bienvenu B, Karras A, Guillevin L, Caillat-Zucman S. 2011. Excessive interleukin-15 transpresen-tation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener’s). Arthritis Rheum 63:2116–2126. https://doi.org/10.1002/art.30355.
39. Abadie V, Jabri B. 2014. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev 260:221–234. https://doi.org/10.1111/imr.12191.
40. Bobbala D, Chen XL, Leblanc C, Mayhue M, Stankova J, Tanaka T, Chen YG, Ilangumaran S, Ramanathan S. 2012. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia 55:3010–3020. https://doi.org/10.1007/s00125-012-2675-1.
41. Miyagawa F, Tagaya Y, Kim BS, Patel HJ, Ishida K, Ohteki T, Waldmann TA, Katz SI. 2008. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol 181:1109–1119. https://doi.org/10.4049/jimmunol.181.2.1109.
42. Di Sabatino A, Calarota SA, Vidali F, Macdonald TT, Corazza GR. 2011. Role of IL-15 in immune-mediated and infectious diseases. Cytokine Growth Factor Rev 22:19–33. https://doi.org/10.1016/j.cytogfr.2010.09.003.
43. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, Parren PW, Gracie JA, Jongbloed S, Liew FY, McInnes IB. 2005. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52:2686–2692. https://doi.org/10.1002/art.21249.
44. Kim YS, Maslinski W, Zheng XX, Stevens AC, Li XC, Tesch GH, Kelley VR, Strom TB. 1998. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 160:5742–5748.
45. Howland KC, Ausubel LJ, London CA, Abbas AK. 2000. The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol 164: 4465–4470. https://doi.org/10.4049/jimmunol.164.9.4465.
46. Perez-Melgosa M, Hollenbaugh D, Wilson CB. 1999. CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens. J Immunol 163:1123–1127.
47. Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA. 1999. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 163:3116–3122.
48. Cervera R, Khamashta MA, Hughes GR. 1990. ’Overlap’ syndromes. Ann Rheum Dis 49:947–948. https://doi.org/10.1136/ard.49.11.947.
49. Edington GM, White HA. 1972. The pathology of Lassa fever. Trans R Soc Trop Med Hyg 66:381–389. https://doi.org/10.1016/0035-9203(72) 90268-4.
50. Knobloch J, McCormick JB, Webb PA, Dietrich M, Schumacher HH, Dennis E. 1980. Clinical observations in 42 patients with Lassa fever. Tropenmed Parasitol 31:389–398.
51. Walker DH, McCormick JB, Johnson KM, Webb PA, Komba-Kono G, Elliott LH, Gardner JJ. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107:349–356.
52. Winn WC, Jr, Monath TP, Murphy FA, Whitfield SG. 1975. Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. Arch Pathol 99:599–604.
53. Winn WC, Jr, Walker DH. 1975. The pathology of human Lassa fever. Bull World Health Organ 52:535–545.
54. Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, Schmaljohn CS. 2013. Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation. Vaccines 1:262–277. https://doi.org/10.3390/vaccines1030262.
55. Cashman KA, Smith MA, Twenhafel NA, Larson RA, Jones KF, Allen RD, III, Dai D, Chinsangaram J, Bolken TC, Hruby DE, Amberg SM, Hensley LE, Guttieri MC. 2011. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res 90:70–79. https://doi.org/10.1016/j.antiviral.2011.02.012.